Ben is the founder and CEO of Cellibre, a next-generation biotechnology company that is ushering in the next great industrial revolution by treating biology as a manufacturing technology. Cellibre turns cells into specialized, sustainable factories for the manufacture of globally significant products at scale. The company’s world-class scientific team has led programs from napkin to commercial, pioneering revolutionary breakthroughs in energy, ingredients, medicines and more. Cellibre’s initial strategic focus will be deploying their expertise to enable the production of pharmaceutical-grade cannabinoids by brewing them like beer, alleviating the need for agriculture entirely and revolutionizing the way cannabinoid-based medicines are sourced, produced and consumed.
Ben formally worked with Dr. J Craig Venter and Nobel Laureate Dr. Ham Smith as the Vice President of Corporate Development and Strategy at Synthetic Genomics where he was responsible for defining, evolving and implementing SGI’s strategy across all of its franchises. In that context, he facilitated and managed the portfolio of internal initiatives, strategic partnerships and transactions from inception to closing including sourcing, funding, negotiation and post-deal integration, execution, and monitoring. Ben joined SGI from Millennium Health, a leading medication solutions company focused on solving the opioid epidemic, where he led the strategy and corporate development efforts. Prior to joining the industry, Ben had a nine-year tenure on Wall Street, most recently with J.P. Morgan’s healthcare investment banking group where he advised clients on mergers and acquisitions as well as debt and equity financings. In his career on Wall Street, he executed over $20 billion in transactions.
Ben earned his MBA from Carnegie Mellon University’s Tepper School of Business and his B.S. in Mechanical Engineering from Case Western Reserve University. He is also the co-founder of ConvenCare as well as the 32/21 Foundation and serves on the boards of American Made Liner Systems, ConvenCare, the 32/21 Foundation, and 83bar.